November 9, 2012: SASI’s report was recently cited in the report, U.S. and European Philanthropic Support to Address HIV/AIDS in 2011, by Funders Concerned About AIDS (FCAA) and the European HIV/AIDS Funders Group (EFG).
This report highlights the gaps in the South, which has the highest rate of new HIV infections and the largest number of PLWHA in the U.S. The South also has more AIDS diagnosis and AIDS deaths than any other U.S. region. In 2010, 47% of estimated new HIV infections were in the South, and at the end of 2009, 41% of PLWH in the U.S. were living in the South.1
This report also highlights the gaps in linkages to care, with only 25% of PLWH in the U.S. receiving continuous care and treatment; harm reduction, with a federal funding ban on needle and syringe programs; and Black Americans and MSMs, which account for a disproportionate percentage of new HIV infections.
Other highlights from the report include:
- In 2011, total HIV/AIDS philanthropic funding was $644 million (a 5% increased over 2010).
- In 2011, U.S.-based funders dispersed $491 million for HIV/AIDS (a 3% increase over 2010, although the majority of U.S.-based funders decreased HIV/AIDS funding in 2011). This disbursement funded 5,561 HIV/AIDS-related projects and grants.
- Of this $491 million, $221 million was directed towards global projects, $179 million was directed towards non-U.S. countries and regions, and $98 million was directed towards the U.S. epidemic.
- Of this $98 million, $23 million was directed towards prevention, $21 million was directed towards treatment, and $21 million was directed towards social services. U.S. funding targeted African Americans, MSMs, and homeless/impoverished PLWHA.
- In 2011, the South received $28 million in philanthropic HIV/AIDS funding. The South and the Northeast received the highest share of U.S. funding.
- The leading U.S. philanthropic funders in the South were M*A*C AIDS Fund & M*A*C Cosmetics ($4,101,288); Bristol-Myers Squibb Foundation & Bristol-Myers Squibb Co. ($3,493,685); AIDS United ($3,204,403); Gilead Sciences, Inc. ($2,708,013) The Ford Foundation ($2,655,000).
In addition to this report, FCAA has created a Funders’ Guide to the National HIV/AIDS Strategy.
1 Centers for Disease Control and Prevention. HIV Surveillance Report, Vol. 22, 2012. Available at www.cdc.gov/hiv/surveillance/resources/reports/2010report/index.htm.